Angiotensin Receptor Agonistic Autoantibody Is Highly Prevalent in Preeclampsia: Correlation With Disease Severity

Hypertension - United States
doi 10.1161/hypertensionaha.109.140061
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Role of Angiotensin II Type I Receptor Agonistic Autoantibodies (AT1-AA) in Preeclampsia

Current Opinion in Pharmacology
Drug DiscoveryPharmacology
2011English

Lipoxin A4 Suppresses Angiotensin II Type 1 Receptor Autoantibody in Preeclampsia via Modulating Caspase-1

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2020English

Role of Agonistic Autoantibodies Against Type-1 Angiotensin II Receptor in the Pathogenesis of Retinopathy in Preeclampsia

Scientific Reports
Multidisciplinary
2016English

Response to Questionable Role of the Angiotensin II Receptor Subtype 1 Autoantibody in the Pathogenesis of Preeclampsia: There Is No Single Universal Preeclampsia Cause

Hypertension
Internal Medicine
2007English

Dupuytren Disease Is Highly Prevalent in Male Field Hockey Players Aged Over 60 Years

British Journal of Sports Medicine
Sports MedicinePhysical TherapySports ScienceSports TherapyOrthopedicsMedicineRehabilitation
2016English

Hypertension and Chronic Kidney Disease Is Highly Prevalent in Elderly Patients With Colorectal Cancer Undergoing Primary Surgery

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Autoantibody-Mediated Complement C3a Receptor Activation Contributes to the Pathogenesis of Preeclampsia

Hypertension
Internal Medicine
2012English

The Correlation Between Immunoexpression of Estrogen Receptor and the Severity of Periodontal Disease

Dental Journal (Majalah Kedokteran Gigi)
2010English

Periodontal Disease Is Not Associated With Preeclampsia in Canadian Pregnant Women

Journal of Periodontology
Periodontics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy